Search by Drug Name or NDC
NDC 61919-0309-71 LISINOPRIL AND HYDROCHLOROTHIAZIDE 25; 20 mg/1; mg/1 Details
LISINOPRIL AND HYDROCHLOROTHIAZIDE 25; 20 mg/1; mg/1
LISINOPRIL AND HYDROCHLOROTHIAZIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by DIRECT RX. The primary component is HYDROCHLOROTHIAZIDE; LISINOPRIL.
Product Information
NDC | 61919-0309 |
---|---|
Product ID | 61919-309_f99cf980-0243-611f-e053-6394a90ab543 |
Associated GPIs | 36991802550320 |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | LISINOPRIL AND HYDROCHLOROTHIAZIDE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | LISINOPRIL AND HYDROCHLOROTHIAZIDE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 25; 20 |
Active Ingredient Units | mg/1; mg/1 |
Substance Name | HYDROCHLOROTHIAZIDE; LISINOPRIL |
Labeler Name | DIRECT RX |
Pharmaceutical Class | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA077912 |
Listing Certified Through | 2024-12-31 |
Package
NDC 61919-0309-71 (61919030971)
NDC Package Code | 61919-309-71 |
---|---|
Billing NDC | 61919030971 |
Package | 100 TABLET in 1 BOTTLE (61919-309-71) |
Marketing Start Date | 2015-01-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |